Esomeprazole 20 MG / naproxen 500 MG Delayed Release Oral Tablet — RxCUI 994008
RxNorm drug concept · Semantic clinical drug
RxCUI 994008
Semantic clinical drug · SCD
● Current RxNorm concept 17 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI994008
Official nameEsomeprazole 20 MG / naproxen 500 MG Delayed Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaproxen 500 MG / esomeprazole magnesium 20 MG Delayed Release Oral Tablet
FDA products mapped17
Package NDCs mapped36
Reported Medicaid activity (SDUD)2,982 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Esomeprazole Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The IV form is used when you can't swallow or absorb oral medication — for example, if you're recovering from a procedure, having surgery, or are too unwell to take anything by mou...
- Why am I getting esomeprazole through an IV instead of just taking a pill?
- That depends on what it's being used for. For GERD with esophagitis, it's approved for up to 10 days via IV — and your team will move you to oral esomeprazole as soon as possible....
- How long will I be on this IV medication?
🕸️ Concept Web — How Esomeprazole 20 MG / naproxen 500 MG Delayed Rel... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Esomeprazole 20 MG / naproxen 500 MG Delayed Release Oral Tablet
RxCUI 994008 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Esomeprazole
283742IN -
Naproxen
7258IN -
Esomeprazole / naproxen
994202MIN
-
Esomeprazole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vimovo
1372705BN
-
Vimovo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Esomeprazole / naproxen Delayed Release Oral Tablet
977953SCDF -
Esomeprazole / naproxen Oral Product
1164523SCDG -
Esomeprazole / naproxen Pill
1164524SCDG -
Esomeprazole / naproxen Delayed Release Oral Tablet [Vimovo]
977957SBDF -
Vimovo Oral Product
1186604SBDG -
Vimovo Pill
1186607SBDG -
Delayed Release Oral Tablet
10312DF -
Oral Product
1151131DFG - +1 more in this family
-
Esomeprazole / naproxen Delayed Release Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Esomeprazole 20 MG
343355SCDC -
Naproxen 500 MG
316328SCDC -
Esomeprazole 20 MG / naproxen 500 MG Delayed Release Oral Tablet [Vimovo]
994010SBD -
Esomeprazole 20 MG / naproxen 500 MG [Vimovo]
994009SBDC
-
Esomeprazole 20 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Esomeprazole 20 MG
SCDC · 343355 -
Naproxen 500 MG
SCDC · 316328 -
Esomeprazole / naproxen Delayed Release Oral Tablet
SCDF · 977953 -
Esomeprazole / naproxen Oral Product
SCDG · 1164523 -
Esomeprazole / naproxen Pill
SCDG · 1164524
Brand-Name Concepts
-
Esomeprazole 20 MG / naproxen 500 MG Delayed Release Oral Tablet [Vimovo]
SBD · 994010 -
Esomeprazole 20 MG / naproxen 500 MG [Vimovo]
SBDC · 994009 -
Esomeprazole / naproxen Delayed Release Oral Tablet [Vimovo]
SBDF · 977957 -
Vimovo Oral Product
SBDG · 1186604 -
Vimovo Pill
SBDG · 1186607 -
Vimovo
BN · 1372705
📦 FDA Products & Package NDCs
17 products · 36 package NDCs
36 package NDCs map to RxCUI 994008 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27241-0202-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (27241-202-60) | Naproxen and esomeprazole magnesium | Ajanta Pharma USA Inc. | 2022-10-06 |
| 27241-0203-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (27241-203-60) | Naproxen and esomeprazole magnesium | Ajanta Pharma USA Inc. | 2022-10-06 |
| 50228-0437-10 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-437-10) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2023-10-11 |
| 50228-0437-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-437-30) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2023-10-11 |
| 50228-0437-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-437-60) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2024-03-12 |
| 50228-0438-05 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-438-05) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2023-10-11 |
| 50228-0438-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-438-30) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2023-10-11 |
| 50228-0438-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (50228-438-60) | Naproxen and esomeprazole magnesium | ScieGen Pharmaceuticals, Inc | 2024-03-12 |
| 55111-0289-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (55111-289-60) | Naproxen and esomeprazole magnesium | Dr. Reddy's Laboratories Limited | 2020-02-18 |
| 55111-0701-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (55111-701-60) | Naproxen and esomeprazole magnesium | Dr. Reddy's Laboratories Limited | 2020-02-18 |
| 63629-4873-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (63629-4873-1) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-17 |
| 63629-4873-02 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (63629-4873-2) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-17 |
| 68788-4043-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4043-3) | Naproxen and esomeprazole magnesium | Preferred Pharmaceuticals Inc. | 2025-10-17 |
| 68788-4043-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4043-6) | Naproxen and esomeprazole magnesium | Preferred Pharmaceuticals Inc. | 2025-10-17 |
| 68788-8766-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8766-3) | Naproxen and esomeprazole magnesium | Preferred Pharmaceuticals Inc. | 2024-11-08 |
| 68788-8766-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8766-6) | Naproxen and esomeprazole magnesium | Preferred Pharmaceuticals Inc. | 2024-11-08 |
| 69306-0005-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (69306-005-60) | Naproxen and esomeprazole magnesium | Doc Rx | 2026-05-27 |
| 71335-2552-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2552-1) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-21 |
| 71335-2552-02 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2552-2) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-21 |
| 71335-2553-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2553-1) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-23 |
| 71335-2553-02 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2553-2) | Naproxen and esomeprazole magnesium | Bryant Ranch Prepack | 2025-01-23 |
| 76420-0889-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-889-01) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0889-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-889-30) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0889-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-889-60) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0889-90 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-889-90) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0890-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-890-01) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0890-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-890-30) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0890-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-890-60) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 76420-0890-90 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-890-90) | Naproxen and esomeprazole magnesium | Asclemed USA, Inc. | 2024-12-28 |
| 82804-0276-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (82804-276-60) | Naproxen and esomeprazole magnesium | Proficient Rx LP | 2026-03-31 |
| 85509-1203-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1203-1) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2025-08-01 |
| 85509-1203-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1203-3) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2025-07-21 |
| 85509-1438-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1438-1) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2026-03-03 |
| 85509-1438-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1438-3) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2026-03-03 |
| 85509-1438-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1438-6) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2026-03-03 |
| 85509-1438-09 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1438-9) | Naproxen and esomeprazole magnesium | PHOENIX RX LLC | 2026-03-03 |
Observed labelers:
Asclemed USA, Inc. (8) ·
Bryant Ranch Prepack (6) ·
PHOENIX RX LLC (6) ·
ScieGen Pharmaceuticals, Inc (6) ·
Preferred Pharmaceuticals Inc. (4) ·
Ajanta Pharma USA Inc. (2)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.